The post RAY Technical Analysis Feb 4 appeared on BitcoinEthereumNews.com. RAY is approaching the critical support zone ($0.6360) in a strong downtrend, with RSIThe post RAY Technical Analysis Feb 4 appeared on BitcoinEthereumNews.com. RAY is approaching the critical support zone ($0.6360) in a strong downtrend, with RSI

RAY Technical Analysis Feb 4

4 min read

RAY is approaching the critical support zone ($0.6360) in a strong downtrend, with RSI at 24.60 signaling oversold; however, MACD is negative and it’s failing to hold above EMA20 ($0.89), bearish outlook persists.

Executive Summary

RAY/USD is trading at $0.65 as of February 4, 2026, having experienced a 4.56% decline in 24 hours. The overall technical picture is bearish: Supertrend resistance at $0.91, price below EMA20 ($0.89), RSI at 24.60 oversold but MACD negative histogram fails to support momentum. Critical support at $0.6360 (79/100 score), resistance at $0.7173. Bitcoin’s downtrend is creating pressure on altcoins; risk/reward ratio unfavorable toward bearish target ($0.1024). Long-term recovery requires close above $0.7829.

Market Structure and Trend Status

Current Trend Analysis

RAY is in a clear downtrend across 1D and higher timeframes. Price has declined nearly 70% from recent highs, retreating to the lower band of the main channel. Supertrend indicator giving bearish signal and positioning $0.91 as resistance. Closures below short-term EMA20 ($0.89) and EMA50 ($1.02) show no signal of trend reversal. Multi-timeframe analysis (1D/3D/1W) identifies 9 strong levels: 1D with 1 support/4 resistances, 3D with 1S/1R, 1W with 2S/2R. This requires breaking multiple resistances for upward movement.

Structural Levels

Main structural supports: $0.6360 (high-volume pivot, 79/100 score). Lower supports extend to around $0.50 from 1W timeframe. Resistance layers: $0.7173 (63/100), $0.7829 (63/100), and $1.1277 (63/100, bullish target). These levels align with past swing high/lows and Fibonacci retracements. Upward movement cannot be sustained without trendline break.

Technical Indicators Report

Momentum Indicators

RSI(14): 24.60 in oversold territory (below 30), warning of short-term bounce potential but no divergence. MACD: Bearish crossover active, histogram negative and expanding below zero line; momentum supports downside. Stochastic %K 15.2, %D 22.4 – both oversold, may signal local bottom. CCI -180 confirms oversold. Overall momentum confluence bearish but oversold conditions imply approaching reversal.

Trend Indicators

EMAs: Price below EMA20 ($0.89), EMA50 ($1.02), and EMA200 ($1.45); death cross (EMA20

Critical Support and Resistance Analysis

Supports: Primary $0.6360 (79/100, 1D/3D confluence, volume base). Secondary $0.58-$0.60 (1W support). Break below targets $0.50 and ultimate $0.1024 bearish target (22 score). Resistance: $0.69 daily high, $0.7173 (63/100, near EMA20), $0.7829 (Fib 0.382), $1.1277 (Fib 0.618, 53 score bullish target). These levels supported by volume profile and order blocks. Failure to hold $0.6360 carries high cascade risk.

Volume and Market Participation

24h volume $1.82M, below average (20% low); declining volume on downside indicates weak sellers. OBV negative divergence: Price making new lows while OBV holds higher, accumulation building. VWAP above $0.67 signals institutional interest. Futures open interest low, spot dominance limits speculative moves. Resistance break impossible without volume increase; volume test at $0.6360 critical.

Risk Assessment

From current $0.65, bullish target $1.1277 offers RR 1:1.73 (73% up), bearish $0.1024 at 1:4.1 (84% down) – net bearish asymmetry. Main risk: BTC downside correlation causing altcoin cascade, $0.6360 break. Positive scenario: RSI bounce tests $0.7173 (stop $0.63). Negative: Volume-less drop to $0.50. Volatility 5.2% (average), max drawdown risk 15%. Wait for $0.7173 for longs, short on $0.69+ break. Detailed data available in RAY Spot Analysis and RAY Futures Analysis.

Bitcoin Correlation

BTC at $73,212 (-3.26%), in downtrend; Supertrend bearish. RAY correlates 0.85 with BTC – if BTC $71,888 support breaks, RAY $0.6360 test accelerates. BTC resistance $73,937 failure increases general altcoin pressure. Watch: BTC below $68,853 = RAY cascade risk; BTC above $76,927 = altcoin rotation. Rising dominance (52%+) against RAY.

Conclusion and Strategic Outlook

RAY’s technical chart shows bearish dominance: Oversold momentum offers short-term bounce potential ($0.7173 target), but trend remains bearish via Supertrend and EMAs. Critical support $0.6360 – hold leads to $0.7829 rally, break opens path to $0.50. Aggressive longs risky without BTC recovery; short bias prevails (RR favorable). Long-term: HODL signal above $1.1277. Strategy: Dip buyers long $0.6360 (TP $0.7173, SL $0.62); trend followers short $0.69 break. No market news flow, stay technical-focused. This holistic view supported by multi-indicator confluence – integrate spot and futures analysis for decisions.

This analysis uses Chief Analyst Devrim Cacal’s market views and methodology.

Strategy Analyst: David Kim

Macro market analysis and portfolio management

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/analysis/ray-comprehensive-technical-analysis-detailed-review-of-february-4-2026

Market Opportunity
4 Logo
4 Price(4)
$0,01143
$0,01143$0,01143
+%0,97
USD
4 (4) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

President Donald Trump told NBC News' Tom Llamas in an interview released on Wednesday that he has no interest in actually keeping any money he wins from his lawsuit
Share
Rawstory2026/02/05 10:43
US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

The post US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike appeared on BitcoinEthereumNews.com. US President Donald Trump said that
Share
BitcoinEthereumNews2026/02/05 10:23
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11